Screening for uterine tumours

T Van den Bosch, A Coosemans, M Morina… - Best practice & research …, 2012 - Elsevier
The most prevalent uterine tumours are leiomyomas, which are benign and have a
prevalence of about 50% at menopause. The incidence of endometrial cancer and uterine …

Abnormal uterine and post-menopausal bleeding in the acute gynaecology unit

T Bignardi, T Van den Bosch, G Condous - Best Practice & Research …, 2009 - Elsevier
Abnormal uterine bleeding is one of the most common presentations in the acute
gynaecology unit. The general principles of emergency care, including assessment of …

European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology

A Herbert, C Bergeron, H Wiener, U Schenck… - …, 2007 - Wiley Online Library
There are many different systems of cytology classification used in the member states of the
European Union (EU) and many different languages. The following short annexe to Chapter …

The revised BSCC terminology for abnormal cervical cytology

KJ Denton, A Herbert, LS Turnbull, C Waddell… - 2008 - Wiley Online Library
The BSCC terminology was originally published in 1986 and although highly successful,
requires revision. Through a process of professional consensus and literature review this …

Endometrial cells in cervical cytology: review of cytological features and clinical assessment

DL Greenspan, M Cardillo, DD Davey… - Journal of lower …, 2006 - journals.lww.com
The 2001 Bethesda System for Reporting Cervical Cytology recommends reporting benign
exfoliated endometrial cells in women age 40 and older, and a review of the literature …

Proteomic identification of dihydrolipoamide dehydrogenase as a target of autoantibodies in patients with endometrial cancer

K Yoneyama, R Shibata, A Igarashi, S Kojima… - Anticancer …, 2014 - ar.iiarjournals.org
Background/Aim: Accumulating evidence shows that various types of cancers induce a
specific immune response, resulting in the production of antibodies against self-components …

The value of Papanicolaou tests in the diagnosis of endometrial carcinoma: a large study cohort from an academic medical center

K Serdy, I Yildiz-Aktas, Z Li… - American journal of clinical …, 2016 - academic.oup.com
Objectives: To determine on a large scale whether routine cervical Papanicolaou (Pap) tests
play a role in endometrial carcinoma diagnosis. Methods: A retrospective search of an …

Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women's hospital laboratory

Z Li, C Gilbert, H Yang, C Zhao - American journal of clinical …, 2012 - academic.oup.com
Abstract We studied 1,183 Papanicolaou (Pap) cytology cases (739 with normal endometrial
cells [nEMCs], 423 with atypical EMCs [aEMCs], and 21 with endometrial cancer cells …

[HTML][HTML] Significance of finding benign endometrial cells in women 40–45 versus 46 years or older on Papanicolaou tests and histologic follow-up

SM Colletti, GA Tranesh, A Nassar - Cytojournal, 2017 - ncbi.nlm.nih.gov
Background: The 2014 Bethesda System recommends reporting the finding of benign-
appearing, exfoliated endometrial cells on Papanicolaou (Pap) tests in women aged 45 …

Age cut‐off for reporting endometrial cells on a P apanicolaou test: 50 years may be more appropriate than 45 years

VL Weiss, F Cate, L Bloom, O Fadare… - …, 2016 - Wiley Online Library
Objective The 2001 Bethesda System for Reporting Cervical Cytology includes
documenting'endometrial cells in women≥ 40 years of age '(E40) to help identify …